View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Revance Therapeutics Inc: 1 director

A director at Revance Therapeutics Inc sold 34,853 shares at 17.577USD and the significance rating of the trade was 77/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
ACM AECOM
EME EMCOR GROUP ... (+16)

Vermilion Compass: Weekly Equity Strategy

Another Bear Market Rally Brewing? In last week's Compass (Sept. 27) we discussed our belief that the market indexes could see a bounce or pause in selling, citing numerous oversold indexes/Sectors that were testing critical supports, including 3636 on the S&P 500, $269 on the Nasdaq 100 (QQQ), and $162 on the Russell 2000 (IWM). Sector and index supports held, and early indications suggest a bear market rally is brewing, and potentially that the lows are in for this bear market, helped by shor...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Tables: December 11, 2021

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

COP CONOCOPHILLIPS
IBTX INDEPENDENT BANK GROUP INC.
INCY INCYTE CORP
CBT CABOT CORPORATION
ZION ZIONS BANCORPORATION N.A.
WLK WESTLAKE CHEMICAL CORPORATION
TXRH TEXAS ROADHOUSE INC.
STLD STEEL DYNAMICS INC.
SCCO SOUTHERN COPPER CORPORATION
SBCF SEACOAST BANKING CORPORATION OF FLORIDA
RYN RAYONIER INC.
RVNC REVANCE THERAPEUTICS INC.
RUTH RUTH'S HOSPITALITY GROUP INC.
PENN PENN NATIONAL GAMING INC.
MNTA MOMENTA PHARMACEUTICALS INC.
MD MEDNAX INC.
LVS LAS VEGAS SANDS CORP.
LAZ LAZARD LTD CLASS A
KE KIMBALL ELECTRONICS
IRWD IRONWOOD PHARMACEUTICALS INC. CLASS A
IP INTERNATIONAL PAPER COMPANY
INGN INOGEN INC.
IMMU IMMUNOMEDICS INC.
IGT INTERNATIONAL GAME TECHNOLOGY PLC
HTBK HERITAGE COMMERCE CORP.
HRTX HERON THERAPEUTICS INC
HL HECLA MINING COMPANY
HALO HALOZYME THERAPEUTICS INC.
HA HAWAIIAN HOLDINGS INC.
H HYATT HOTELS CORPORATION CLASS A
GT GOODYEAR TIRE & RUBBER COMPANY
GS GOLDMAN SACHS GROUP INC.
FMBI FIRST MIDWEST BANCORP INC.
FCX FREEPORT-MCMORAN INC.
ENS ENERSYS
EMN EASTMAN CHEMICAL COMPANY
EDIT EDITAS MEDICINE INC.
CTRN CITI TRENDS INC.
CMC COMMERCIAL METALS COMPANY
CHS CHICO'S FAS INC.
BYD BOYD GAMING CORPORATION
BMTC BRYN MAWR BANK CORP.
D8Q BANCO LATINOAMERICANO DE COMERCIO EXTERIOR S.A. CLASS E
BGSF BG STAFFING INC
B BARNES GROUP INC.
ASTE ASTEC INDUSTRIES INC.
ASB ASSOCIATED BANC-CORP
ALSN ALLISON TRANSMISSION HOLDINGS INC.
AIT APPLIED INDUSTRIAL TECHNOLOGIES INC.
AEL AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY
VRS VERSO CORPORATIN
GDEN GOLDEN ENTERTAINMENT
ACLS AXCELIS TECHNOLOGIES INC.
BBBY BED BATH & BEYOND INC.
CENT CENTRAL GARDEN & PET COMPANY
OIS OIL STATES INTERNATIONAL INC.
UNVR UNIVAR SOLUTIONS INC.
NTNX NUTANIX INC. CLASS A
BWFG BANKWELL FINANCIAL GROUP
JELD JELD-WEN HOLDING INC.
PLPC PREFORMED LINE PRODUCTS CO.
ENR ENERGIZER HOLDINGS INC.
KNX KNIGHT-SWIFT TRANSPORTATION HOLDINGS INC. CLASS A
BXS BANCORPSOUTH BANK
SPB SPECTRUM BRANDS HOLDINGS INC.
VRCA VERRICA PHARMACEUTICALS
NTB BANK OF N.T. BUTTERFIELD & SON
DTIL PRECISION BIOSCIENCES
CNR CORNERSTONE BUILDING BRANDS INC
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

UFI UNIFI INC
BAC BANK OF AMERICA CORP
SWK STANLEY BLACK & DECKER INC.
VAC MARRIOTT VACATIONS WORLDWIDE CORPORATION
PNC PNC FINANCIAL SERVICES GROUP INC.
C CITIGROUP INC.
ZEUS OLYMPIC STEEL INC.
WD5 TRAVEL + LEISURE CO.
WFC WELLS FARGO & COMPANY
VC VISTEON CORPORATION
ULH UNIVERSAL LOGISTICS HOLDINGS INC.
UCTT ULTRA CLEAN HOLDINGS INC.
TTMI TTM TECHNOLOGIES INC.
TSLA TESLA INC
TSE TRINSEO SA
SFBS SERVISFIRST BANCSHARES INC
RVNC REVANCE THERAPEUTICS INC.
RNST RENASANT CORPORATION
RF REGIONS FINANCIAL CORPORATION
PZZA PAPA JOHN'S INTERNATIONAL INC.
PSMT PRICESMART INC.
PRGO PERRIGO CO. PLC
POL AVIENT CORPORATION
PII POLARIS INC.
PCH POTLATCHDELTIC CORPORATION
PBF PBF ENERGY INC. CLASS A
OLBK OLD LINE BANCSHARES INC.
MPC MARATHON PETROLEUM CORPORATION
DLY LYONDELLBASELL INDUSTRIES NV
LFUS LITTELFUSE INC.
LAZ LAZARD LTD CLASS A
KPTI KARYOPHARM THERAPEUTICS
KEM KEMET CORPORATION
JWN NORDSTROM INC.
IVC INVACARE CORPORATION
IPHS INNOPHOS HOLDINGS INC.
HUN HUNTSMAN CORPORATION
HBAN HUNTINGTON BANCSHARES INCORPORATED
HA HAWAIIAN HOLDINGS INC.
FBC FLAGSTAR BANCORP INC.
ECHO ECHO GLOBAL LOGISTICS INC
EBS EMERGENT BIOSOLUTIONS INC.
CMC COMMERCIAL METALS COMPANY
CFX COLFAX CORPORATION
BKE BUCKLE INC.
BG BUNGE LIMITED
AXE ANIXTER INTERNATIONAL INC.
TK TEEKAY CORPORATION
VSEC VSE CORP
BC BRUNSWICK CORPORATION
INTL INTL FCSTONE
MCK MCKESSON CORPORATION
DOOR MASONITE INTERNATIONAL CORP.
CSTE CAESARSTONE LTD.
CAH CARDINAL HEALTH INC.
EV EATON VANCE CORP.
HFC HOLLYFRONTIER CORPORATION
MINI MOBILE MINI INC.
SCVL SHOE CARNIVAL INC.
SGMS SCIENTIFIC GAMES CORPORATION
VMI VALMONT INDUSTRIES INC.
INBK FIRST INTERNET BANCORP
RRD R.R. DONNELLEY & SONS COMPANY
WBT WELBILT INC
LCII LCI INDUSTRIES
APTV APTIV PLC
KNX KNIGHT-SWIFT TRANSPORTATION HOLDINGS INC. CLASS A
SGH SMART GLOBAL HOLDINGS INC.
HOG HARLEY-DAVIDSON INC.
ADNT ADIENT PLC
COOP MR. COOPER GROUP INC.
FXP PROSHARES ULTRASHORT FTSE CHINA 50
WW WW INTERNATIONAL
INC.
 PRESS RELEASE

Revance Appoints Former Allergan Marketing Veteran Taryn Conway as Vic...

NEWARK, Calif.--(BUSINESS WIRE)-- Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company developing next-generation neuromodulators for use in treating aesthetic and therapeutic conditions, today announced a pivotal addition to its leadership team with the appointment of Taryn Conway as Vice President, Marketing, effective April 8, 2019. As the company transitions from clinical-stage development to commercialization, Ms. Conway will be an integral architect of product launch strategies and implementation, reporting to Head...

 PRESS RELEASE

SAKURA 3 Trial Results Presented on Podium at World’s Largest Medica...

NEWARK, Calif.--(BUSINESS WIRE)-- Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company developing next-generation neuromodulators for use in treating aesthetic and therapeutic conditions, today announced podium and poster presentations of its SAKURA 3 Phase 3 open-label, long-term safety study of DaxibotulinumtoxinA for Injection (DAXI) for the treatment of glabellar (frown) lines at the 17th Aesthetics & Anti-Aging Medical World Congress (AMWC). The leading international conference was held April 4 - 6 in Monte-Carlo, M...

 PRESS RELEASE

Revance to Participate in the Needham Healthcare Conference

NEWARK, Calif.--(BUSINESS WIRE)-- Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company developing next-generation neuromodulators for use in treating aesthetic and therapeutic conditions, today announced that the Company will participate in the Needham Healthcare Conference in New York, NY. Chief Financial Officer, Tobin Schilke, is scheduled to present on Tuesday, April 9 at 12:00pm ET. Interested parties can access the live audio webcast for this conference from the Investor Relations section of the c...

 PRESS RELEASE

Revance to Participate in Upcoming Investor Conferences

NEWARK, Calif.--(BUSINESS WIRE)-- Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company developing next-generation neuromodulators for use in treating aesthetic and therapeutic conditions, today announced that the Company will participate in two upcoming investor conferences. President and Chief Executive Officer, Dan Browne, is scheduled to present at the Cowen and Company 39th Annual Health Care Conference in Boston, MA on Tuesday, March 12 at 9:20am ET. Chief Financial Officer, Tobin Schilke, is sched...

 PRESS RELEASE

Revance Releases Fourth Quarter and Full Year 2018 Results

NEWARK, Calif.--(BUSINESS WIRE)-- Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company developing next-generation neuromodulators for use in treating aesthetic and therapeutic conditions, today announced results for the fourth quarter and full year ended December 31, 2018 and provided a business update. Recent Highlights for DaxibotulinumtoxinA for Injection (DAXI) and Upcoming Company Milestones DAXI demonstrated unprecedented efficacy and duration in alleviating moderate-to-severe gl...

 PRESS RELEASE

Revance to Release Fourth Quarter and Full Year 2018 Financial Results...

NEWARK, Calif.--(BUSINESS WIRE)-- Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company developing next-generation neuromodulators for use in treating aesthetic and therapeutic conditions, today announced that the Company will release fourth quarter and full year 2018 financial results on Tuesday, February 26, 2019 after the close of market. Revance will host a corresponding conference call and a live webcast at 1:30pm PT/4:30pm ET on the same day to discuss the results and provide a business and pipeline update. ...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch